Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 319 M347 M341 M333 M333 M380 M 1.39 B Research & development 149 M153 M151 M154 M150 M156 M 611 M Operating income -9 M-11 M-3 M-11 M36 M-10 M 12 M Non-Operating Income, Total 22 M18 M18 M19 M16 M13 M 66 M Interest expense, net of interest capitalized 5 M5 M3 M5 M4 M6 M 18 M Non-Operating Income, excl. Interest Expenses -5 M-5 M-3 M-5 M-4 M-6 M -18 M Unusual income/expense 22 M18 M18 M19 M16 M13 M 66 M Pretax income 8 M2 M12 M3 M48 M-3 M 60 M Equity in earnings —————— — Taxes 002 M02 M1 M 5 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 8 M2 M10 M3 M46 M-4 M 55 M Discontinued operations —————— — Net income 8 M2 M10 M3 M46 M-4 M 55 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 8 M2 M10 M3 M46 M-4 M 55 M Basic earnings per share (Basic EPS) 0.030.010.040.010.19-0.02 0.22 Diluted earnings per share (Diluted EPS) 0.030.010.040.010.19-0.02 0.22 Average basic shares outstanding 242.26 M241.08 M242.33 M241.93 M235.68 M227.9 M — Diluted shares outstanding 256.19 M251.66 M256.24 M254.12 M239.64 M227.9 M — EBITDA 195 M222 M249 M232 M290 M265 M 1.04 B EBIT 130 M155 M182 M167 M225 M200 M 774 M Cost of revenue 139 M166 M185 M178 M189 M210 M 762 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 65 M67 M67 M65 M65 M65 M 262 M